Correlation Between Cardio Diagnostics and YS Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and YS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and YS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and YS Biopharma Co, you can compare the effects of market volatilities on Cardio Diagnostics and YS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of YS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and YS Biopharma.

Diversification Opportunities for Cardio Diagnostics and YS Biopharma

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Cardio and YS Biopharma is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and YS Biopharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on YS Biopharma and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with YS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of YS Biopharma has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and YS Biopharma go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and YS Biopharma

Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 2.45 times more return on investment than YS Biopharma. However, Cardio Diagnostics is 2.45 times more volatile than YS Biopharma Co. It trades about 0.01 of its potential returns per unit of risk. YS Biopharma Co is currently generating about -0.11 per unit of risk. If you would invest  1,001  in Cardio Diagnostics Holdings on April 21, 2024 and sell it today you would lose (950.00) from holding Cardio Diagnostics Holdings or give up 94.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy47.58%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  YS Biopharma Co

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cardio Diagnostics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in August 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
YS Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days YS Biopharma Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, YS Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Cardio Diagnostics and YS Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and YS Biopharma

The main advantage of trading using opposite Cardio Diagnostics and YS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, YS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in YS Biopharma will offset losses from the drop in YS Biopharma's long position.
The idea behind Cardio Diagnostics Holdings and YS Biopharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios